New Jersey · 2026-2027 Regular Session · Bill

S 1102: Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

In committee Last action January 13, 2026: Introduced in the Senate, Referred to Senate Commerce Committee

Plain-language summary

S 1102 is a bill introduced in the New Jersey Senate on January 13, 2026. According to its official title, it concerns: Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease. Primary sponsor: Nilsa Cruz-Perez (Democratic). Most recent recorded action (January 13, 2026): Introduced in the Senate, Referred to Senate Commerce Committee.

Sponsors

Primary sponsor: Nilsa Cruz-Perez (Democratic).